Halozyme Therapeutics (HALO) Asset Writedowns and Impairment (2019 - 2020)
Halozyme Therapeutics (HALO) reported Asset Writedowns and Impairment of $52000.0 for Q4 2020, down 95.39% year-over-year from $1.1 million in Q1 2020, and down 95.39% quarter-over-quarter from $1.1 million in Q4 2019.
Halozyme Therapeutics (HALO) Asset Writedowns and Impairment (2019 - 2020) Analysis & Trends
Halozyme Therapeutics (HALO) has 2 years of Asset Writedowns and Impairment data on file, last reported at $52000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Halozyme Therapeutics | 8.24 Bn | 7.92 Bn | 297.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 52,000.00 |
| Dec 31, 2020 | 52,000.00 |
| Dec 31, 2019 | 1.13 Mn |
| Dec 31, 2019 | 1.13 Mn |